We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$388M
AUM Growth
+$41.7M
Cap. Flow
+$16.2M
Cap. Flow %
4.17%
Top 10 Hldgs %
24.25%
Holding
310
New
44
Increased
124
Reduced
95
Closed
9

Top Sells

Rank Stock Value
1
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$2.47M
2
SYNA icon
Synaptics
SYNA
+$1.51M
3
CAT icon
Caterpillar
CAT
+$1.47M
4
WFC icon
Wells Fargo
WFC
+$1.2M
5
CVS icon
CVS Health
CVS
+$858K

Sector Composition

Rank Sector Weight
1 Healthcare 16.34%
2 Technology 14.94%
3 Financials 10.75%
4 Industrials 9.18%
5 Energy 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
151
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$642K 0.17%
11,936
+6,232
+109% +$321K
LQD icon
152
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$642K 0.17%
5,015
+1,672
+50% +$213K
TGT icon
153
Target
TGT
$66.3B
$635K 0.16%
+4,949
New +$581K
K
154
DELISTED
Kellanova
K
$634K 0.16%
9,769
+1
+0% +$61
HPQ icon
155
HP
HPQ
$26B
$631K 0.16%
30,705
+1,884
+7% +$35.7K
VTI icon
156
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$627K 0.16%
3,834
-459
-11% -$71.9K
HSY icon
157
Hershey
HSY
$37.3B
$626K 0.16%
4,258
-249
-6% -$36.9K
PPL
158
PPL Corp
PPL
$26.9B
$625K 0.16%
17,433
-6,281
-26% -$211K
A icon
159
Agilent Technologies
A
$39.6B
$614K 0.16%
7,197
+800
+13% +$63K
COP icon
160
ConocoPhillips
COP
$144B
$602K 0.16%
+9,258
New +$544K
GLD icon
161
SPDR Gold Trust
GLD
$131B
$598K 0.15%
4,185
+870
+26% +$122K
NVS icon
162
Novartis
NVS
$302B
$597K 0.15%
6,304
USB icon
163
US Bancorp
USB
$97.9B
$573K 0.15%
9,661
-482
-5% -$27.9K
IJH icon
164
iShares Core S&P Mid-Cap ETF
IJH
$121B
$571K 0.15%
13,860
-1,650
-11% -$65.4K
ATR icon
165
AptarGroup
ATR
$8.69B
$570K 0.15%
4,934
WAL icon
166
Western Alliance Bancorporation
WAL
$8.81B
$570K 0.15%
10,000
SYNA icon
167
Synaptics
SYNA
$4.05B
$559K 0.14%
8,500
-28,599
-77% -$1.51M
MET icon
168
MetLife
MET
$62.4B
$556K 0.14%
10,907
+2
+0% +$97
GDX icon
169
VanEck Gold Miners ETF
GDX
$22.5B
$553K 0.14%
18,900
+100
+0.5% +$2.73K
PWR icon
170
Quanta Services
PWR
$84.2B
$547K 0.14%
+13,436
New +$548K
MDLZ icon
171
Mondelez International
MDLZ
$82.9B
$546K 0.14%
9,921
-4,630
-32% -$248K
C icon
172
Citigroup
C
$213B
$542K 0.14%
6,786
+1,749
+35% +$129K
SPY icon
173
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$538K 0.14%
1,672
+531
+47% +$164K
ETN icon
174
Eaton
ETN
$141B
$537K 0.14%
5,665
-596
-10% -$52.9K
UHT
175
Universal Health Realty Income Trust
UHT
$621M
$525K 0.14%
+4,475
New +$510K

Similar funds

Boenning & Scattergood's Q4 2019 Portfolio in Review

As of Q4 2019, Boenning & Scattergood held 310 positions worth $388M, up 12% from $346M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boenning & Scattergood deployed $16.2M of net new capital in Q4 2019, opening 44 new positions and adding to 124 existing holdings. Its largest new stake was Global X MLP & Energy Infrastructure ETF: 26,475 shares worth $975K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SPDR Gold MiniShares Trust, an estimated $2.47M trimmed.

  • Boenning & Scattergood's largest Q4 2019 buy was Global X MLP & Energy Infrastructure ETF: 26,475 shares worth $975K.
  • Boenning & Scattergood added most to Microsoft in Q4 2019, an estimated $1.37M increase.
  • Boenning & Scattergood's biggest Q4 2019 reduction was SPDR Gold MiniShares Trust, cutting an estimated $2.47M.
  • Boenning & Scattergood fully exited Vanguard Total International Stock ETF in Q4 2019, selling an estimated $730K.
  • Boenning & Scattergood's ten largest holdings make up 24% of its $388M portfolio in Q4 2019.
  • Boenning & Scattergood opened 44 new positions and closed 9 in Q4 2019.
  • Boenning & Scattergood's portfolio value rose 12% quarter-over-quarter to $388M.

Based on Boenning & Scattergood's 13F filing for Q4 2019, filed 15 Jan 2020.